Effect of Pemafibrate on Cerebrovascular Atherosclerosis in Patients with Stroke and Hypertriglyceridemia
Pemafibrate was observed to have TG-lowering and anti-inflammatory effects and could attenuate atherosclerosis progression in the intra- and extracranial arteries of patients with stroke and hypertriglyceridemia.
Authors
- Megumi Hosoya (ORCID: https://orcid.org/0009-0000-2817-9119)
- Satoko Arai (ORCID: https://orcid.org/0000-0003-1636-7184)
- Shuntaro Takahashi
- Sho Wako (ORCID: https://orcid.org/0000-0002-3271-3799)
- Rie Oshima
- Kentaro Ishizuka (ORCID: https://orcid.org/0000-0002-9571-7148)
- Takao Hoshino (ORCID: https://orcid.org/0000-0002-2477-9755)
- Kazuo Kitagawa (ORCID: https://orcid.org/0000-0002-7669-231X)
- Sono Toi (ORCID: https://orcid.org/0000-0003-1990-4707)
- Misa Seki (ORCID: https://orcid.org/0000-0002-8578-5454)
- Takafumi Mizuno (ORCID: https://orcid.org/0000-0002-7843-594X)
Institutions
- Tokyo Women's Medical University Hospital (JP)
- Tokyo Women's Medical University Adachi Medical Center (JP)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2024-11-29
- DOI
- https://doi.org/10.5551/jat.65277
- Citations
- 4
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.68